Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude

European Respiratory Journal

Volumn 15, Issue 4, 2000, Pages 635-639

  Christensen, C C ^a,b,c,d   Ryg, M ^b,c   Refvem, O K ^c   Skjonsberg O H ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Institute of Aviation Medicine   (Norway)

^c Glittreklinikken AS   (Norway)

^d Glittreklinikken   (Norway)

Author keywords

Cabin pressure altitude; Chronic obstructive pulmonary disease; Commercial aircraft; Hypoxaemia

Indexed keywords

OXYGEN;

ADULT; AGED; ALTITUDE DISEASE; ARTERIAL OXYGEN TENSION; ARTICLE; AVIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE EXACERBATION; EXERCISE; HUMAN; HYPOXEMIA; MALE; PRIORITY JOURNAL;

EID: 0034086384     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00.15463500     Document Type: Article

References (22)

1. Matthys H, Volz H, Ernst H, Konietzko N, Kleeberg HR. Kardiopulmonale Belastung von Flugpassagieren mit obstruktiven Ventilationsstörungen. Schweiz med Wschr 1974; 104: 1786-1789.
2. Code of Federal Regulations. Title 14, Vol. 1, Part 25. 1527. Washington, DC, US Government Printing Office, 1999.
3. Harding RM, Mills JF. Problems of altitude I: hypoxia and hyper-ventilation. BMJ 1983; 286: 1408-1410.
4. Code of Federal Regulations. Title 14, Vol. 1, Part 121. 327. Washington, DC, US Government Printing Office, 1999.
5. Cottrell JJ. Altitude exposures during aircraft flight. Flying higher. Chest 1988; 93: 81-84.
6. Gong H. Air travel and oxygen therapy in cardiopulmonary patients. Chest 1992; 101: 1104-1113.
7. Aerospace Medical Association, Air transport medicine committee. Medical guidelines for air travel. Aviat Space Environ Med 1996; 67: B1-B16.
8. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S112-S113.
9. AMA Commision on Emergency Medical Services. Medical aspects of transportation aboard commercial aircraft. JAMA 1982; 247: 1007-1011.
10. Gong H Jr. Advising pulmonary patients about commer-cial air travel. J Respir Dis 1990; 11: 484-499.
11. Vohra KP, Klocke RA. Detection and correction of hypoxaemia associated with air travel. Am Rev Respir Dis 1993; 148: 1215-1219.
12. Mills JF, Harding RM. Fitness to travel by air. BMJ 1983; 286: 1269-1271.
13. Gong H Jr., Tashkin DP, Simmons MS. Hypoxia-altitude simulation test. Am Rev Respir Dis 1984; 135: 980-986.
14. Mercer A, Brown JD. Venous thromboembolism associated with air travel: a report of 33 patients. Aviat Space Environ Med 1998; 69: 154-157.
15. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S78-S83.
16. Dillard TA, Berg BW, Rajagopal KR, Dooley JW, Mehm WJ. Hypoxemia during air travel in patients with chronic obstructive pulmonary disease. Ann Intern Med 1989; 111: 362-367.
17. McArdle WD, Katch FI, Katch VL. Exercise physiology. Philadelphia, USA, Lea and Fabiger, 1991.
18. Schwartz JS, Bencowitz HZ, Moser KM. Air travel hypoxaemia with chronic obstructive pulmonary disease. Ann Intern Med 1984; 100: 473-477.
19. Rayman RB. Passenger safety, health and comfort: a review. Aviat Space Environ Med 1997; 68: 5: 432-440.
20. Speizer C, Rennie C, Breton H. Prevalence of in-flight medical emergencies on commercial airlines. Ann Emerg Med 1989; 18: 26-29.
21. Gong H, Lee Mark JA, Cowan MN. Pre-flight medical screenings of patients. Analysis of health and flight characteristics. Chest 1993; 104: 788-794.
22. Nicholas R, O'Meara PD, Calonge N. Is syncope related to moderate altitude exposure? JAMA 1992; 268: 904-906.